Ovunhipita 75 mg tablets

Ovunhipita 75 mg tablets

Description:

Ovunhipita 75 mg tablets are an oral hormonal contraceptive medicine containing the progestin desogestrel. It is used as a progestogen-only pill (mini-pill) for reliable prevention of pregnancy in women of reproductive age. By inhibiting ovulation and thickening cervical mucus, Ovunhipita helps prevent fertilization and implantation when taken correctly every day at the same time. This product is intended for prescription-guided use under medical supervision.

Indications:

• Hormonal contraception for women of reproductive age who wish to prevent pregnancy.
• Suitable for women who cannot use estrogen-containing combined oral contraceptives (e.g., due to risk factors such as smoking over age 35, migraine with aura, history of venous thromboembolism, or estrogen intolerance), as assessed by a doctor.
• May be used during breastfeeding after medical evaluation, as progestogen-only pills are often preferred over combined pills in lactating women.
• Helps regulate menstrual cycles in some users, with possible reduction in menstrual pain and bleeding, although bleeding patterns may become irregular.

Active Ingredients / Key Components:

• Desogestrel – 75 mg per tablet (progestogen-only oral contraceptive).
• Excipients (inactive ingredients) – not specified in available information; may include standard tablet fillers, binders, and coatings. Exact composition is not available.

Dosage & Administration / How to Use:

• Recommended dose: 1 tablet (75 mg desogestrel) taken orally once daily, every day at the same time, with or without food, as directed by your doctor.
• Tablets are taken continuously with no tablet-free interval: start a new pack the day after finishing the previous one.
• Starting for the first time: usually start on day 1 of the menstrual cycle (first day of bleeding). Your doctor may advise a different start day; follow medical advice.
• Switching from another hormonal contraceptive: follow your doctor’s instructions for transition from combined pills, other progestin-only pills, injection, implant, or intrauterine device to ensure continuous contraceptive protection.
• Postpartum or after abortion: timing of initiation depends on breastfeeding status and medical assessment; consult your healthcare provider.
• Missed dose: if you are more than 12 hours late taking a tablet, contraceptive protection may be reduced. Take the missed tablet as soon as you remember and take the next tablet at the usual time (this may mean taking two tablets in one day). Use additional non-hormonal contraception (e.g., condoms) for at least 7 days and consult your doctor or pharmacist for detailed guidance.
• Vomiting or severe diarrhea within 3–4 hours after taking a tablet may reduce absorption; take another tablet as soon as possible and follow missed-dose advice.
• Do not exceed the prescribed daily dose. Use only under medical supervision and follow your doctor’s instructions and the patient information leaflet.

Clinical Benefits:

• Provides effective, daily oral contraception when taken consistently at the same time each day.
• Progestogen-only formulation (desogestrel) offers an option for women who cannot or prefer not to use estrogen-containing contraceptives.
• Inhibits ovulation and thickens cervical mucus, significantly reducing the likelihood of sperm reaching and fertilizing an egg.
• May be suitable during breastfeeding after medical evaluation, as progestin-only pills generally have minimal impact on breast milk quantity and quality.
• Convenient tablet form allows discreet, non-invasive daily contraceptive management without injections or devices.

Warnings & Contraindications:

• Use only after consultation with a healthcare professional to ensure this contraceptive is appropriate for you.
• Contraindicated in women with known or suspected pregnancy.
• Contraindicated in women with active or history of severe liver disease, liver tumors, or unexplained jaundice until liver function has returned to normal.
• Contraindicated in women with known or suspected sex hormone–dependent malignancies (e.g., certain breast or endometrial cancers) or a history of such cancers, unless clearly advised by a specialist.
• Contraindicated in case of undiagnosed vaginal bleeding until the cause has been evaluated.
• Use with caution in women with a history of thromboembolic disorders, cardiovascular disease, diabetes, hypertension, migraine, or depression; regular medical follow-up is recommended.
• Ovunhipita 75 mg tablets do not protect against sexually transmitted infections (STIs) or HIV/AIDS. Use condoms for STI protection.
• Inform your doctor about all medications, herbal products, or supplements you are taking. Certain medicines (e.g., some antiepileptics, rifampicin, rifabutin, some HIV/hepatitis C medicines, St. John’s wort) may reduce contraceptive effectiveness.
• Consult your doctor before use if pregnant, planning pregnancy, nursing, or if you have medical conditions such as liver disease, kidney disease, diabetes, high blood pressure, migraine, or history of blood clots.
• Not intended to diagnose, treat, cure, or prevent any disease other than contraception.
• Keep out of reach of children.

Side Effects:

• Common side effects may include irregular menstrual bleeding (spotting, prolonged bleeding, or absence of periods), breast tenderness, headache, mood changes, acne, weight changes, and nausea.
• Less common side effects may include decreased libido, abdominal pain, ovarian cysts, or changes in vaginal discharge.
• Serious but rare side effects can include signs of blood clots (sudden leg pain or swelling, chest pain, shortness of breath), severe abdominal pain, jaundice (yellowing of skin or eyes), or signs of an allergic reaction (rash, itching, swelling of face/lips/tongue, difficulty breathing). Seek immediate medical attention if these occur.
• If you experience persistent, severe, or unusual symptoms, contact your doctor or pharmacist promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children.

Specifications:

• Form: Tablets for oral use.
• Strength: 75 mg desogestrel per tablet.
• Pack size: 28 tablets per pack (28 tabs) – 28-day continuous contraceptive regimen.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.